Literature DB >> 2406000

Second cancers and other late side effects of cancer treatment. A review.

J F Boivin1.   

Abstract

The author reviewed the question of late side effects of cancer treatment. A late side effect was defined as an unwanted and deleterious effect observed for the first time 12 months or longer after treatment. In a survey of articles published by The New England Journal of Medicine and The Lancet from 1968 to 1988, nine categories of late side effects were identified: second cancers, hormonal and reproductive effects, effects on the immunologic system, heart disease, effects on kidney and urinary bladder, effects on gastrointestinal organs, neurologic and psychological effects, pulmonary toxicity, and osteonecrosis. The induction of second cancers is a particularly important late side effect of cancer treatment. Several epidemiologic studies demonstrated increased risks of leukemia and solid tumors in patients exposed to radiotherapy. Large increases in leukemia risk have also been observed after chemotherapy with alkylating agents. However, several research questions remain unanswered, including the duration of the excess cancer risk after treatment, and the independent effect of various drugs on second cancer risk.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2406000     DOI: 10.1002/1097-0142(19900201)65:3+<770::aid-cncr2820651323>3.0.co;2-8

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  3 in total

Review 1.  Open questions and novel concepts in oral cancer surgery.

Authors:  Giancarlo Tirelli; Serena Zacchigna; Matteo Biasotto; Marco Piovesana
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-05-24       Impact factor: 2.503

2.  Surviving and thriving with cancer using a Web-based health behavior change intervention: randomized controlled trial.

Authors:  Erin O'Carrol Bantum; Cheryl L Albright; Kami K White; Jeffrey L Berenberg; Gabriela Layi; Phillip L Ritter; Diana Laurent; Katy Plant; Kate Lorig
Journal:  J Med Internet Res       Date:  2014-02-24       Impact factor: 5.428

3.  Cytotoxicity of the Aqueous Extract and Organic Fractions from Origanum majorana on Human Breast Cell Line MDA-MB-231 and Human Colon Cell Line HT-29.

Authors:  Hanane Makrane; Mouhcine El Messaoudi; Ahmed Melhaoui; Mohammed El Mzibri; Laila Benbacer; Mohammed Aziz
Journal:  Adv Pharmacol Sci       Date:  2018-08-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.